Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMoonLake Immunotherapeutics Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.87 | -$0.64 | -$0.75 |
| Q2 2025 | 7 | -$0.81 | -$0.68 | -$0.74 |
| Q3 2025 | 7 | -$0.98 | -$0.62 | -$0.88 |
| Q4 2025 | 7 | -$1.15 | -$0.74 | -$0.98 |
| Q1 2026 | 2 | -$0.92 | -$0.92 | -$0.92 |
| Q2 2026 | 1 | -$0.94 | -$0.94 | -$0.94 |
| Q3 2026 | 1 | -$0.95 | -$0.95 | -$0.95 |
| Q4 2026 | 1 | -$0.96 | -$0.96 | -$0.96 |
MoonLake Immunotherapeutics Earnings Date And Information
MoonLake Immunotherapeutics last posted its earnings results on Wednesday, November 5th, 2025. The company reported $-1.1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.89 by $0.21. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MoonLake Immunotherapeutics has generated $-2 earnings per share over the last year ($-1.89 diluted earnings per share) and currently has a price-to-earnings ratio of -5.38. MoonLake Immunotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 25th, 2026 based on prior year's report dates.
MoonLake Immunotherapeutics Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2025 | Q3 2025 | -$0.89 | -$1.10 | -0.21 | $0 | $0 |
| 08/05/2025 | Q2 2025 | -$0.73 | -$0.87 | -0.14 | $0 | $0 |
| 05/12/2025 | Q1 2025 | -$0.76 | -$0.63 | 0.13 | $0 | $0 |
| 02/26/2025 | Q4 2024 | -$0.53 | -$0.72 | -0.19 | $101.85 K | $0 |
| 11/07/2024 | Q3 2024 | -$0.44 | -$0.56 | -0.12 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$0.28 | -$0.39 | -0.11 | $0 | $0 |
| 05/07/2024 | Q1 2024 | -$0.21 | -$0.22 | -0.01 | N/A | $0 |
| 05/07/2024 | Q4 2023 | -$0.21 | -$0.12 | 0.09 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.18 | N/A | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.25 | -$0.23 | 0.02 | N/A | $0 |
| 05/11/2023 | Q1 2023 | N/A | -$0.31 | N/A | N/A | $0 |
| 03/20/2023 | Q4 2022 | -$0.32 | -$0.05 | 0.27 | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.32 | -$0.40 | -0.08 | N/A | $0 |
| 08/12/2022 | Q2 2022 | -$0.54 | -$0.49 | 0.05 | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$0.43 | N/A | N/A | $0 |
| 02/17/2022 | Q4 2021 | N/A | -$0.06 | N/A | N/A | $0 |
| 11/12/2021 | Q3 2021 | N/A | -$0.17 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$0.89 | N/A | N/A | $0 |
| 05/21/2021 | Q1 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2021 | Q4 2020 | N/A | -$0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics Earnings: FAQ's
MoonLake Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 25th, 2026 based offlast year's report dates.
The conference call for MoonLake Immunotherapeutics's latest earnings report can be listened to online.
The conference call transcript for MoonLake Immunotherapeutics's latest earnings report can be read online.
MoonLake Immunotherapeutics (:MLTX) has a recorded net income of $-118,935,517.MoonLake Immunotherapeutics has generated $-1.89 earnings per share over the last four quarters.
MoonLake Immunotherapeutics (:MLTX) has a price-to-earnings ratio of -5.38 and price/earnings-to-growth ratio is 0.26.